{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:59:31Z","timestamp":1773079171717,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.diagmicrobio.2006.01.029","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T02:20:11Z","timestamp":1146795611000},"page":"333-336","source":"Crossref","is-referenced-by-count":22,"title":["Ceftobiprole medocaril (BAL5788) treatment of experimental Haemophilus influenzae, Enterobacter cloacae, and Klebsiella pneumoniae murine pneumonia"],"prefix":"10.1016","volume":"55","author":[{"given":"Mark S.","family":"Rouse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie M.","family":"Hein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Anguita-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Steckelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/AAC.48.4.1105-1111.2004","article-title":"Efficacy of BAL5788, a prodrug of cephalosporin BAL9141, in a mouse model of acute pneumococcal pneumonia","volume":"48","author":"Azoulay-Dupuis","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/jac\/dkg457","article-title":"Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center","volume":"52","author":"Bozdogan","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/AAC.49.3.884-888.2005","article-title":"Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus","volume":"49","author":"Chambers","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib4","series-title":"Methods for determining bactericidal activity of antimicrobial agents; approved guideline","author":"Clinical and Laboratory Standards Institute","year":"1999"},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib5","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib6","series-title":"Maxipime product insert","author":"Elan Biopharmaceuticals","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/AAC.46.1.171-177.2002","article-title":"BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis","volume":"46","author":"Entenza","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/AAC.45.3.825-836.2001","article-title":"In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci","volume":"45","author":"Hebeisen","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib9","series-title":"Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2004","first-page":"380","article-title":"BAL5788, the first of a new class of anti-MRSA cephalosporins: microbiological results from a phase II study in complicated skin and skin structure infections","author":"Heep","year":"2004"},{"issue":"Suppl. 3","key":"10.1016\/j.diagmicrobio.2006.01.029_bib10","first-page":"163","article-title":"Development of endogenous resistance by staphylococci to BAL9141 and comparators","volume":"10","author":"Heller","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib11","series-title":"Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago IL, 2003","first-page":"233","article-title":"In vitro activity of BAL9141, a broad spectrum pyrrolidinone cephalosporin, against Klebsiella pneumoniae isolates possessing extended spectrum beta-lactamases (ESBLs)","author":"Hujer","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2003.09.006","article-title":"In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria","volume":"48","author":"Issa","year":"2004","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jac\/dkf249","article-title":"In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci","volume":"50","author":"Jones","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib14","series-title":"Antibiotics in laboratory medicine","first-page":"230","article-title":"Measurement of antibiotics in human body fluids: techniques and significance","author":"Klassen","year":"1996"},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib15","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/AAC.49.5.1932-1942.2005","article-title":"Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin","volume":"49","author":"Kosowska","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/AAC.43.3.708","article-title":"Ketolide treatment of Haemophilus influenzae experimental pneumonia","volume":"43","author":"Piper","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib18","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1128\/AAC.48.7.2570-2575.2004","article-title":"Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers","volume":"48","author":"Schmitt-Hoffmann","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib19","series-title":"44th Interscience Conference on Antimicrobial Agents and Chemotherapy","first-page":"48","article-title":"Intensive therapy with BAL5788 of experimental foreign body infection due to methicillin-resistant Staphylococcus aureus (MRSA)","author":"Vaudaux","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2006.01.029_bib20","series-title":"Laboratory procedures in clinical microbiology","author":"Washington","year":"1985"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T12:25:34Z","timestamp":1555590334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889306000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0732889306000538"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2006.01.029","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}